Mass Diagnostic Instrumentssp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2021-05-11
Share capital
20,000.00 PLN
Registered address
ul. Czesława Przybylskiego 11/112, 02-777 Warszawa, Poland
Electronic delivery address
AE:PL-82788-61223-JUGIS-21
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 748 days for 2021).
- 2024not filed
- 202301/08/2024
- 202201/08/2024
- 202101/08/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Zbigniew Szamel – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 400 | $5,402.49 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiResearch institute | $355,967,543.57 | cskmswia.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Proper Medical Writingsp. z o.o. | $464,661.64 | propermedicalwriting.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com | ||
| LASTsp. z o.o. | – | last-skincare.com |
FAQ
The main business activity of Mass Diagnostic Instruments focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on May 11, 2021.
The headquarters is located at: ul. Czesława Przybylskiego 11, 02-777 Warszawa.
The management board consists of: Zbigniew Szamel (President of the Management Board).
The share capital of the company is PLN 20,000 (approx. $5,402).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
Last updated: 2026-10-07